These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1414 related articles for article (PubMed ID: 15286445)

  • 1. Evaluation of recombinant and native timothy pollen (rPhl p 1, 2, 5, 6, 7, 11, 12 and nPhl p 4)- specific IgG4 antibodies induced by subcutaneous immunotherapy with timothy pollen extract in allergic patients.
    Rossi RE; Monasterolo G
    Int Arch Allergy Immunol; 2004 Sep; 135(1):44-53. PubMed ID: 15286445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible relationship between systemic side effects and sensitization to rPar j 2 in allergic patients submitted to an ultra-rush (20 min) sublingual immunotherapy and selected by component resolved diagnosis.
    Rossi RE; Monasterolo G; Coco G; Operti D
    Int Arch Allergy Immunol; 2005 Oct; 138(2):105-10. PubMed ID: 16174987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of serum IgG4 antibodies specific to grass pollen allergen components in the follow up of allergic patients undergoing subcutaneous and sublingual immunotherapy.
    Rossi RE; Monasterolo G; Coco G; Silvestro L; Operti D
    Vaccine; 2007 Jan; 25(5):957-64. PubMed ID: 17045368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgE profiles of Bermuda grass pollen sensitised patients evaluated by Phleum pratense allergens Phl P 1, 2, 4, 5, 6 , 7, 11, 12.
    Rossi RE; Monasterolo G; Prina P; Coco G; Operti D; Rossi L
    Allergol Int; 2008 Jun; 57(2):157-64. PubMed ID: 18349590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular profiles of IgE to Phleum pratense in children with grass pollen allergy: implications for specific immunotherapy.
    Tripodi S; Frediani T; Lucarelli S; Macrì F; Pingitore G; Di Rienzo Businco A; Dondi A; Pansa P; Ragusa G; Asero R; Faggian D; Plebani M; Matricardi PM
    J Allergy Clin Immunol; 2012 Mar; 129(3):834-839.e8. PubMed ID: 22206774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pretreatment IgE sensitization patterns determine the molecular profile of the IgG4 response during updosing of subcutaneous immunotherapy with timothy grass pollen extract.
    Schmid JM; Würtzen PA; Dahl R; Hoffmann HJ
    J Allergy Clin Immunol; 2016 Feb; 137(2):562-70. PubMed ID: 26141262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific subcutaneous immunotherapy with recombinant grass pollen allergens: first randomized dose-ranging safety study.
    Klimek L; Schendzielorz P; Pinol R; Pfaar O
    Clin Exp Allergy; 2012 Jun; 42(6):936-45. PubMed ID: 22909165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skin test with a timothy grass (Phleum pratense) pollen extract vs. IgE to a timothy extract vs. IgE to rPhl p 1, rPhl p 2, nPhl p 4, rPhl p 5, rPhl p 6, rPhl p 7, rPhl p 11, and rPhl p 12: epidemiological and diagnostic data.
    Mari A
    Clin Exp Allergy; 2003 Jan; 33(1):43-51. PubMed ID: 12534548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy with a Phleum pratense allergen extract induces an immune response to a grass-mix allergen extract.
    Martínez-Cócera C; Sastre J; Cimarra M; Quirce S; Fernández-Rivas M; Enríquez-Matas A; Rodríguez-Alvarez M; Martín S
    J Investig Allergol Clin Immunol; 2010; 20(1):13-9. PubMed ID: 20232769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allergens. Heterogeneity of molecular sensitization profiles in grass pollen allergy--implications for immunotherapy?
    Darsow U; Brockow K; Pfab F; Jakob T; Petersson CJ; Borres MP; Ring J; Behrendt H; Huss-Marp J
    Clin Exp Allergy; 2014; 44(5):778-86. PubMed ID: 24598010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phleum pratense alone is sufficient for allergen-specific immunotherapy against allergy to Pooideae grass pollens.
    Hejl C; Wurtzen PA; Kleine-Tebbe J; Johansen N; Broge L; Ipsen H
    Clin Exp Allergy; 2009 May; 39(5):752-9. PubMed ID: 19222498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneity of commercial timothy grass pollen extracts.
    Focke M; Marth K; Flicker S; Valenta R
    Clin Exp Allergy; 2008 Aug; 38(8):1400-8. PubMed ID: 18564332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant allergen-based monitoring of antibody responses during injection grass pollen immunotherapy and after 5 years of discontinuation.
    Gadermaier E; Staikuniene J; Scheiblhofer S; Thalhamer J; Kundi M; Westritschnig K; Swoboda I; Flicker S; Valenta R
    Allergy; 2011 Sep; 66(9):1174-82. PubMed ID: 21480924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification, structural and immunological characterization of a timothy grass (Phleum pratense) pollen allergen, Phl p 4, with cross-reactive potential.
    Stumvoll S; Lidholm J; Thunberg R; DeWitt AM; Eibensteiner P; Swoboda I; Bugajska-Schretter A; Spitzauer S; Vangelista L; Kazemi-Shirazi L; Sperr WR; Valent P; Kraft D; Valenta R
    Biol Chem; 2002 Sep; 383(9):1383-96. PubMed ID: 12437131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of IgE antibodies to recombinant pollen allergens (Phl p 1, Phl p 2, and Phl p 5) in a random sample of patients with specific IgE to Phleum pratense.
    Rossi RE; Monasterolo G; Operti D; Operti R; Berlen R
    Allergy; 2000 Feb; 55(2):181-4. PubMed ID: 10726734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nasal allergen-neutralizing IgG
    Shamji MH; Kappen J; Abubakar-Waziri H; Zhang J; Steveling E; Watchman S; Kouser L; Eifan A; Switzer A; Varricchi G; Marone G; Couto-Francisco NC; Calderon M; Durham SR
    J Allergy Clin Immunol; 2019 Mar; 143(3):1067-1076. PubMed ID: 30445057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Grass pollen immunotherapy as an effective therapy for childhood seasonal allergic asthma.
    Roberts G; Hurley C; Turcanu V; Lack G
    J Allergy Clin Immunol; 2006 Feb; 117(2):263-8. PubMed ID: 16461125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spatial clustering of the IgE epitopes on the major timothy grass pollen allergen Phl p 1: importance for allergenic activity.
    Flicker S; Steinberger P; Ball T; Krauth MT; Verdino P; Valent P; Almo S; Valenta R
    J Allergy Clin Immunol; 2006 Jun; 117(6):1336-43. PubMed ID: 16750995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IgE reactivity pattern to timothy and birch pollen allergens in Finnish and Russian Karelia.
    Movérare R; Petays T; Vartiainen E; Haahtela T
    Int Arch Allergy Immunol; 2005 Jan; 136(1):33-8. PubMed ID: 15591811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunologic effect and tolerability of intra-seasonal subcutaneous immunotherapy with an 8-day up-dosing schedule to 10,000 standardized quality-units: a double-blind, randomized, placebo-controlled trial.
    Pfaar O; Wolf H; Klimek L; Schnitker J; Wüstenberg E
    Clin Ther; 2012 Oct; 34(10):2072-81. PubMed ID: 23063373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 71.